PF-AtlasClinical Trials › NCT02129803

Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis

High-Flow, 20 LPM · Not specified

Registry ID
NCT02129803
Phase
Not specified
Status
Completed
Drug / intervention
High-Flow, 20 LPM (via Optiflow cannula)
Sponsor
Virginia Commonwealth University
Start
2015-05
Enrollment
24
Locations
1

About this trial

This study is a single center, randomized pilot study to evaluate the clinical effectiveness of nasal high flow 20LPM humidification therapy in subjects with Cystic Fibrosis.

View NCT02129803 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT02129803 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.